Familial hyperparathyroidism or Hypocalciuric hypercalcaemia: genes and variants
Explore variant evidence for Familial hyperparathyroidism or Hypocalciuric hypercalcaemia across 2 analyzed proteins (CASR, RET). Linked ClinVar records include 5 pathogenic or likely pathogenic variants, 9 variants of uncertain significance and 11 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Familial hyperparathyroidism or Hypocalciuric hypercalcaemia
CASR: Extracellular calcium-sensing receptor
It senses extracellular calcium in the parathyroid gland and kidney and adjusts parathyroid-hormone secretion and renal calcium handling accordingly. Loss-of-function variants cause familial hypocalciuric hypercalcemia or neonatal severe hyperparathyroidism, whereas activating variants cause autosomal dominant hypocalcemia.
5 ClinVar pathogenic / likely pathogenic and 12 uncertain variants in CASR have source records linked to Familial hyperparathyroidism or Hypocalciuric hypercalcaemia. Association strength is not clinical gene validity.
RET: Proto-oncogene tyrosine-protein kinase receptor Ret
Its activation by GDNF-family ligands guides development of the enteric nervous system, kidney, and other tissues. Activating variants cause multiple endocrine neoplasia type 2 and can drive cancer, whereas loss-of-function variants are an important cause of Hirschsprung disease.
0 ClinVar pathogenic / likely pathogenic and 6 uncertain variants in RET have source records linked to Familial hyperparathyroidism or Hypocalciuric hypercalcaemia. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): CDC73 and CDKN1B.
ClinVar pathogenic and likely pathogenic variants linked to Familial hyperparathyroidism or Hypocalciuric hypercalcaemia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CASR S147L | 147 | Ligand-binding 1 (LB1) | Pathogenic / likely pathogenic (★★) |
| CASR T138M | 138 | Ligand-binding 1 (LB1) | Pathogenic / likely pathogenic (★★) |
| CASR G553R | 553 | Cysteine-rich (CR) | Pathogenic / likely pathogenic (★★) |
| CASR F183L | 183 | Ligand-binding 1 (LB1) | Pathogenic / likely pathogenic (★) |
| CASR S171R | 171 | Ligand-binding 1 (LB1) | Pathogenic / likely pathogenic (★) |
Same protein, different disease
- Familial hypocalciuric hypercalcemia also has ClinVar records linked to CASR variants; they fall mostly in different places as the Familial hyperparathyroidism or Hypocalciuric hypercalcaemia variants (81 pathogenic / likely pathogenic).
- Autosomal dominant hypocalcemia also has ClinVar records linked to CASR variants; they fall mostly in different places as the Familial hyperparathyroidism or Hypocalciuric hypercalcaemia variants (69 pathogenic / likely pathogenic).
- Nephrolithiasis/nephrocalcinosis also has ClinVar records linked to CASR variants; they fall mostly in different places as the Familial hyperparathyroidism or Hypocalciuric hypercalcaemia variants (14 pathogenic / likely pathogenic).
- Neonatal severe primary hyperparathyroidism also has ClinVar records linked to CASR variants; they fall mostly in different places as the Familial hyperparathyroidism or Hypocalciuric hypercalcaemia variants (11 pathogenic / likely pathogenic).
- Idiopathic generalized epilepsy also has ClinVar records linked to CASR variants; they fall mostly in different places as the Familial hyperparathyroidism or Hypocalciuric hypercalcaemia variants (8 pathogenic / likely pathogenic).
Diseases related to Familial hyperparathyroidism or Hypocalciuric hypercalcaemia
- Hypertrophic cardiomyopathy, also linked to CASR
- Multiple endocrine neoplasia, also linked to RET
- Gastrointestinal stromal tumor, also linked to RET
- Familial hypocalciuric hypercalcemia, also linked to CASR
- Autosomal dominant hypocalcemia, also linked to CASR
- Pheochromocytoma, also linked to RET
- Ovarian cancer, also linked to RET
- Idiopathic generalized epilepsy, also linked to CASR
- Hirschsprung disease, also linked to RET
- Colorectal cancer, also linked to RET
- Non-small cell lung carcinoma, also linked to RET
- Nephrolithiasis/nephrocalcinosis, also linked to CASR
Frequently asked questions
Which genes have records linked to Familial hyperparathyroidism or Hypocalciuric hypercalcaemia?
This view contains 2 analyzed proteins: CASR, RET. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 5 pathogenic or likely pathogenic variants, 9 variants of uncertain significance and 11 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 25 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center